aluates Reports

$ 0.0

Automative

Global Anticoagulants Market Research Report 2026

Published Date: 2026-02-06

Report Code: QYRE-Auto-18M9167

Global Anticoagulants Market Size Status and Forecast 2022

BUY CHAPTERS

Global Anticoagulants Market Research Report 2026

Code: QYRE-Auto-18M9167

Report

2026-02-06

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Bayer

Johnson & Johnson

Genentech (Roche)

Boehringer Ingelheim

Lilly

Daiichi Sankyo

Otsuka

Astrazeneca plc

Pfizer Inc

Aspen

The Medicines Company

Sanofi

Johnson & Johnson

Anticoagulants Market Size

The global Anticoagulants market was valued at US$ 29630 million in 2025 and is anticipated to reach US$ 40680 million by 2032, at a CAGR of 4.7% from 2026 to 2032.

Anticoagulants Market

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.

North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

This report delivers a comprehensive overview of the global Anticoagulants market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anticoagulants. The Anticoagulants market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Anticoagulants market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Anticoagulants manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Anticoagulants Market Report

Report Metric	Details
Report Name	Anticoagulants Market
Accounted market size in 2025	US$ 29630 million
Forecasted market size in 2032	US$ 40680 million
CAGR	4.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Platelet Aggregation Inhibitors (PAI) Low-Molecular-Weight Heparin (LMWH) Direct Thrombin Inhibitor (DTI) Direct Factor Xa Inhibitors (DFXa) Vitamin K antagonists (VKA) Others
Segment by Application	VTE ACS/MI AF Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo, Otsuka, AstraZeneca, Pfizer, Aspen, The Medicines Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Anticoagulants companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Anticoagulants Market growing?

Ans: The Anticoagulants Market witnessing a CAGR of 4.7% during the forecast period 2026-2032.

What is the Anticoagulants Market size in 2032?

Ans: The Anticoagulants Market size in 2032 will be US$ 40680 million.

What is the Sanofi, Bristol Myers Squibb, Bayer, Genentech (Roche), Boehringer Ingelheim share in Anticoagulants Market?

Ans: Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.

What is the Anticoagulants Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 39%.

Who are the main players in the Anticoagulants Market report?

Ans: The main players in the Anticoagulants Market are Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo, Otsuka, AstraZeneca, Pfizer, Aspen, The Medicines Company

What are the Application segmentation covered in the Anticoagulants Market report?

Ans: The Applications covered in the Anticoagulants Market report are VTE, ACS/MI, AF, Others

What are the Type segmentation covered in the Anticoagulants Market report?

Ans: The Types covered in the Anticoagulants Market report are Platelet Aggregation Inhibitors (PAI), Low-Molecular-Weight Heparin (LMWH), Direct Thrombin Inhibitor (DTI), Direct Factor Xa Inhibitors (DFXa), Vitamin K antagonists (VKA), Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anticoagulants Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Platelet Aggregation Inhibitors (PAI)

1.2.3 Low-Molecular-Weight Heparin (LMWH)

1.2.4 Direct Thrombin Inhibitor (DTI)

1.2.5 Direct Factor Xa Inhibitors (DFXa)

1.2.6 Vitamin K antagonists (VKA)

1.2.7 Others

1.3 Market by Application

1.3.1 Global Anticoagulants Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 VTE

1.3.3 ACS/MI

1.3.4 AF

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Anticoagulants Market Perspective (2021–2032)

2.2 Global Anticoagulants Growth Trends by Region

2.2.1 Global Anticoagulants Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Anticoagulants Historic Market Size by Region (2021–2026)

2.2.3 Anticoagulants Forecasted Market Size by Region (2027–2032)

2.3 Anticoagulants Market Dynamics

2.3.1 Anticoagulants Industry Trends

2.3.2 Anticoagulants Market Drivers

2.3.3 Anticoagulants Market Challenges

2.3.4 Anticoagulants Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Anticoagulants Players by Revenue

3.1.1 Global Top Anticoagulants Players by Revenue (2021–2026)

3.1.2 Global Anticoagulants Revenue Market Share by Players (2021–2026)

3.2 Global Top Anticoagulants Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Anticoagulants Revenue

3.4 Global Anticoagulants Market Concentration Ratio

3.4.1 Global Anticoagulants Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anticoagulants Revenue in 2025

3.5 Global Key Players of Anticoagulants Head Offices and Areas Served

3.6 Global Key Players of Anticoagulants, Products and Applications

3.7 Global Key Players of Anticoagulants, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Anticoagulants Breakdown Data by Type

4.1 Global Anticoagulants Historic Market Size by Type (2021–2026)

4.2 Global Anticoagulants Forecasted Market Size by Type (2027–2032)

5 Anticoagulants Breakdown Data by Application

5.1 Global Anticoagulants Historic Market Size by Application (2021–2026)

5.2 Global Anticoagulants Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Anticoagulants Market Size (2021–2032)

6.2 North America Anticoagulants Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Anticoagulants Market Size by Country (2021–2026)

6.4 North America Anticoagulants Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Anticoagulants Market Size (2021–2032)

7.2 Europe Anticoagulants Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Anticoagulants Market Size by Country (2021–2026)

7.4 Europe Anticoagulants Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Anticoagulants Market Size (2021–2032)

8.2 Asia-Pacific Anticoagulants Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Anticoagulants Market Size by Region (2021–2026)

8.4 Asia-Pacific Anticoagulants Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Anticoagulants Market Size (2021–2032)

9.2 Latin America Anticoagulants Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Anticoagulants Market Size by Country (2021–2026)

9.4 Latin America Anticoagulants Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Anticoagulants Market Size (2021–2032)

10.2 Middle East & Africa Anticoagulants Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Anticoagulants Market Size by Country (2021–2026)

10.4 Middle East & Africa Anticoagulants Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Anticoagulants Introduction

11.1.4 Sanofi Revenue in Anticoagulants Business (2021–2026)

11.1.5 Sanofi Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Details

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb Anticoagulants Introduction

11.2.4 Bristol-Myers Squibb Revenue in Anticoagulants Business (2021–2026)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Anticoagulants Introduction

11.3.4 Bayer Revenue in Anticoagulants Business (2021–2026)

11.3.5 Bayer Recent Development

11.4 Johnson & Johnson.

11.4.1 Johnson & Johnson. Company Details

11.4.2 Johnson & Johnson. Business Overview

11.4.3 Johnson & Johnson. Anticoagulants Introduction

11.4.4 Johnson & Johnson. Revenue in Anticoagulants Business (2021–2026)

11.4.5 Johnson & Johnson. Recent Development

11.5 Genentech (Roche)

11.5.1 Genentech (Roche) Company Details

11.5.2 Genentech (Roche) Business Overview

11.5.3 Genentech (Roche) Anticoagulants Introduction

11.5.4 Genentech (Roche) Revenue in Anticoagulants Business (2021–2026)

11.5.5 Genentech (Roche) Recent Development

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Details

11.6.2 Boehringer Ingelheim Business Overview

11.6.3 Boehringer Ingelheim Anticoagulants Introduction

11.6.4 Boehringer Ingelheim Revenue in Anticoagulants Business (2021–2026)

11.6.5 Boehringer Ingelheim Recent Development

11.7 Lilly

11.7.1 Lilly Company Details

11.7.2 Lilly Business Overview

11.7.3 Lilly Anticoagulants Introduction

11.7.4 Lilly Revenue in Anticoagulants Business (2021–2026)

11.7.5 Lilly Recent Development

11.8 Daiichi Sankyo

11.8.1 Daiichi Sankyo Company Details

11.8.2 Daiichi Sankyo Business Overview

11.8.3 Daiichi Sankyo Anticoagulants Introduction

11.8.4 Daiichi Sankyo Revenue in Anticoagulants Business (2021–2026)

11.8.5 Daiichi Sankyo Recent Development

11.9 Otsuka

11.9.1 Otsuka Company Details

11.9.2 Otsuka Business Overview

11.9.3 Otsuka Anticoagulants Introduction

11.9.4 Otsuka Revenue in Anticoagulants Business (2021–2026)

11.9.5 Otsuka Recent Development

11.10 AstraZeneca

11.10.1 AstraZeneca Company Details

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Anticoagulants Introduction

11.10.4 AstraZeneca Revenue in Anticoagulants Business (2021–2026)

11.10.5 AstraZeneca Recent Development

11.11 Pfizer

11.11.1 Pfizer Company Details

11.11.2 Pfizer Business Overview

11.11.3 Pfizer Anticoagulants Introduction

11.11.4 Pfizer Revenue in Anticoagulants Business (2021–2026)

11.11.5 Pfizer Recent Development

11.12 Aspen

11.12.1 Aspen Company Details

11.12.2 Aspen Business Overview

11.12.3 Aspen Anticoagulants Introduction

11.12.4 Aspen Revenue in Anticoagulants Business (2021–2026)

11.12.5 Aspen Recent Development

11.13 The Medicines Company

11.13.1 The Medicines Company Company Details

11.13.2 The Medicines Company Business Overview

11.13.3 The Medicines Company Anticoagulants Introduction

11.13.4 The Medicines Company Revenue in Anticoagulants Business (2021–2026)

11.13.5 The Medicines Company Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bristol–Myers Squibb

Bayer

Johnson & Johnson

Genentech (Roche)

Boehringer Ingelheim

Lilly

Daiichi Sankyo

Otsuka

Astrazeneca plc

Pfizer Inc

Aspen

The Medicines Company

Sanofi

Johnson & Johnson

List of Tables

Table 1. Global Anticoagulants Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Platelet Aggregation Inhibitors (PAI)

Table 3. Key Players of Low-Molecular-Weight Heparin (LMWH)

Table 4. Key Players of Direct Thrombin Inhibitor (DTI)

Table 5. Key Players of Direct Factor Xa Inhibitors (DFXa)

Table 6. Key Players of Vitamin K antagonists (VKA)

Table 7. Key Players of Others

Table 8. Global Anticoagulants Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Anticoagulants Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Anticoagulants Market Size by Region (US$ Million), 2021–2026

Table 11. Global Anticoagulants Market Share by Region (2021–2026)

Table 12. Global Anticoagulants Forecasted Market Size by Region (US$ Million), 2027–2032

Table 13. Global Anticoagulants Market Share by Region (2027–2032)

Table 14. Anticoagulants Market Trends

Table 15. Anticoagulants Market Drivers

Table 16. Anticoagulants Market Challenges

Table 17. Anticoagulants Market Restraints

Table 18. Global Anticoagulants Revenue by Players (US$ Million), 2021–2026

Table 19. Global Anticoagulants Market Share by Players (2021–2026)

Table 20. Global Top Anticoagulants Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anticoagulants Revenue, 2025

Table 21. Ranking of Global Top Anticoagulants Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Anticoagulants Revenue (CR5 and HHI), 2021–2026

Table 23. Global Key Players of Anticoagulants, Headquarters and Area Served

Table 24. Global Key Players of Anticoagulants, Products and Applications

Table 25. Global Key Players of Anticoagulants, Date of General Availability (GA)

Table 26. Mergers and Acquisitions, Expansion Plans

Table 27. Global Anticoagulants Market Size by Type (US$ Million), 2021–2026

Table 28. Global Anticoagulants Revenue Market Share by Type (2021–2026)

Table 29. Global Anticoagulants Forecasted Market Size by Type (US$ Million), 2027–2032

Table 30. Global Anticoagulants Revenue Market Share by Type (2027–2032)

Table 31. Global Anticoagulants Market Size by Application (US$ Million), 2021–2026

Table 32. Global Anticoagulants Revenue Market Share by Application (2021–2026)

Table 33. Global Anticoagulants Forecasted Market Size by Application (US$ Million), 2027–2032

Table 34. Global Anticoagulants Revenue Market Share by Application (2027–2032)

Table 35. North America Anticoagulants Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. North America Anticoagulants Market Size by Country (US$ Million), 2021–2026

Table 37. North America Anticoagulants Market Size by Country (US$ Million), 2027–2032

Table 38. Europe Anticoagulants Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 39. Europe Anticoagulants Market Size by Country (US$ Million), 2021–2026

Table 40. Europe Anticoagulants Market Size by Country (US$ Million), 2027–2032

Table 41. Asia-Pacific Anticoagulants Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 42. Asia-Pacific Anticoagulants Market Size by Region (US$ Million), 2021–2026

Table 43. Asia-Pacific Anticoagulants Market Size by Region (US$ Million), 2027–2032

Table 44. Latin America Anticoagulants Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Latin America Anticoagulants Market Size by Country (US$ Million), 2021–2026

Table 46. Latin America Anticoagulants Market Size by Country (US$ Million), 2027–2032

Table 47. Middle East & Africa Anticoagulants Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 48. Middle East & Africa Anticoagulants Market Size by Country (US$ Million), 2021–2026

Table 49. Middle East & Africa Anticoagulants Market Size by Country (US$ Million), 2027–2032

Table 50. Sanofi Company Details

Table 51. Sanofi Business Overview

Table 52. Sanofi Anticoagulants Product

Table 53. Sanofi Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 54. Sanofi Recent Development

Table 55. Bristol-Myers Squibb Company Details

Table 56. Bristol-Myers Squibb Business Overview

Table 57. Bristol-Myers Squibb Anticoagulants Product

Table 58. Bristol-Myers Squibb Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 59. Bristol-Myers Squibb Recent Development

Table 60. Bayer Company Details

Table 61. Bayer Business Overview

Table 62. Bayer Anticoagulants Product

Table 63. Bayer Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 64. Bayer Recent Development

Table 65. Johnson & Johnson. Company Details

Table 66. Johnson & Johnson. Business Overview

Table 67. Johnson & Johnson. Anticoagulants Product

Table 68. Johnson & Johnson. Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 69. Johnson & Johnson. Recent Development

Table 70. Genentech (Roche) Company Details

Table 71. Genentech (Roche) Business Overview

Table 72. Genentech (Roche) Anticoagulants Product

Table 73. Genentech (Roche) Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 74. Genentech (Roche) Recent Development

Table 75. Boehringer Ingelheim Company Details

Table 76. Boehringer Ingelheim Business Overview

Table 77. Boehringer Ingelheim Anticoagulants Product

Table 78. Boehringer Ingelheim Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 79. Boehringer Ingelheim Recent Development

Table 80. Lilly Company Details

Table 81. Lilly Business Overview

Table 82. Lilly Anticoagulants Product

Table 83. Lilly Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 84. Lilly Recent Development

Table 85. Daiichi Sankyo Company Details

Table 86. Daiichi Sankyo Business Overview

Table 87. Daiichi Sankyo Anticoagulants Product

Table 88. Daiichi Sankyo Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 89. Daiichi Sankyo Recent Development

Table 90. Otsuka Company Details

Table 91. Otsuka Business Overview

Table 92. Otsuka Anticoagulants Product

Table 93. Otsuka Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 94. Otsuka Recent Development

Table 95. AstraZeneca Company Details

Table 96. AstraZeneca Business Overview

Table 97. AstraZeneca Anticoagulants Product

Table 98. AstraZeneca Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 99. AstraZeneca Recent Development

Table 100. Pfizer Company Details

Table 101. Pfizer Business Overview

Table 102. Pfizer Anticoagulants Product

Table 103. Pfizer Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 104. Pfizer Recent Development

Table 105. Aspen Company Details

Table 106. Aspen Business Overview

Table 107. Aspen Anticoagulants Product

Table 108. Aspen Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 109. Aspen Recent Development

Table 110. The Medicines Company Company Details

Table 111. The Medicines Company Business Overview

Table 112. The Medicines Company Anticoagulants Product

Table 113. The Medicines Company Revenue in Anticoagulants Business (US$ Million), 2021–2026

Table 114. The Medicines Company Recent Development

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

Table 118. Authors List of This Report

List of Figures

Figure 1. Anticoagulants Picture

Figure 2. Global Anticoagulants Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Anticoagulants Market Share by Type: 2025 vs 2032

Figure 4. Platelet Aggregation Inhibitors (PAI) Features

Figure 5. Low-Molecular-Weight Heparin (LMWH) Features

Figure 6. Direct Thrombin Inhibitor (DTI) Features

Figure 7. Direct Factor Xa Inhibitors (DFXa) Features

Figure 8. Vitamin K antagonists (VKA) Features

Figure 9. Others Features

Figure 10. Global Anticoagulants Market Size by Application (US$ Million), 2021–2032

Figure 11. Global Anticoagulants Market Share by Application: 2025 vs 2032

Figure 12. VTE Case Studies

Figure 13. ACS/MI Case Studies

Figure 14. AF Case Studies

Figure 15. Others Case Studies

Figure 16. Anticoagulants Report Years Considered

Figure 17. Global Anticoagulants Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 18. Global Anticoagulants Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Anticoagulants Market Share by Region: 2025 vs 2032

Figure 20. Global Anticoagulants Market Share by Players in 2025

Figure 21. Global Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Anticoagulants Revenue in 2025

Figure 23. North America Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. North America Anticoagulants Market Share by Country (2021–2032)

Figure 25. United States Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Canada Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Anticoagulants Market Share by Country (2021–2032)

Figure 29. Germany Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. France Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. U.K. Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Italy Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Russia Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Ireland Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Anticoagulants Market Share by Region (2021–2032)

Figure 37. China Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Japan Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. South Korea Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Southeast Asia Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. India Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Australia & New Zealand Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Anticoagulants Market Share by Country (2021–2032)

Figure 45. Mexico Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Brazil Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Anticoagulants Market Share by Country (2021–2032)

Figure 49. Israel Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Saudi Arabia Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. UAE Anticoagulants Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Sanofi Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 54. Bayer Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 55. Johnson & Johnson. Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 56. Genentech (Roche) Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 57. Boehringer Ingelheim Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 58. Lilly Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 59. Daiichi Sankyo Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 60. Otsuka Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 61. AstraZeneca Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 62. Pfizer Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 63. Aspen Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 64. The Medicines Company Revenue Growth Rate in Anticoagulants Business (2021–2026)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Anticoagulants Market Research Report 2024

Global Direct Oral Anticoagulant Market Insights Forecast to 2030

Global Anticoagulant Drugs Market Insights Forecast to 2030

Global Injectable Blood Thinners Market Research Report 2025

Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030

Global Anticoagulant Treatment Market Insights Forecast to 2030

Global Anticoagulant Reversal Agent Market Research Report 2024

Global Anticoagulant Medicines Market Research Report 2025

Global Anticoagulation Tube Market Research Report 2025

Global Intravenous Anticoagulants Market Research Report 2024

Sodium Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anticoagulants for Hemodialysis Market Research Report 2024

Global Hemodialysis Anticoagulant Treatment Drugs Market Research Report 2024

Global Heparin Market Insights Forecast to 2030

Global Enoxaparin Sodium Market Research Report 2024

Global Heparin Sodium Market Insights Forecast to 2030

Global Oral Factor Xa Inhibitors Market Research Report 2024

Global Anticoagulant and Non Anticoagulant Rodenticides Market Research Report 2024

Global Factor Xa Inhibitors Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions